glp-1 type 2 diabetes Receptor Agonists and Research to Treat Overeating and Substance Use Disorders GLP-1-based therapies for type 2

doi:10.1111/j.1365-2036.2004.02205.x

Furthermore, the expected shift in population dynamics, with seniors projected to outnumber children under 12 by 2050 underlines their importance in promoting healthy aging and decreasing healthcare burden

Garvey on CagriSema and the Future of Obesity Care Timothy Garvey, MD, of the University of Alabama at Birmingham, reviews the latest data on CagriSema and emerging amylin-based therapies presented at the 2026 ADA Scientific Sessions

Effective treatment combines the right medication with ongoing education and support

A recent study involving 2,517 participants showed that circulating TMAO is not associated with incident dementia

Glutathione | Health Benefits Glutathione therapies provides a range of scientifically validated advantages, thanks to its antioxidant and detoxifying properties